Atrial Fibrillation Trial, Recruiting NCT07278089 Sponsor: Tze-Fan Chao Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07278089
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your left atrium (a chamber in your heart) is enlarged, based on measurements taken during a heart scan
  • The walls of your heart's main pumping chamber are thicker than normal (15mm or more)
  • A specific measurement from your heart ultrasound (called E/e') is above 14, which can suggest your heart is under strain (confirm with trial site)
  • You have been told you have moderate or severe diastolic dysfunction, meaning your heart has difficulty relaxing properly between beats
  • You have a problem with one or more of your heart valves
  • You have heart failure, either where your heart pumps weakly, or where it pumps normally but you have symptoms of heart failure confirmed by specific medical tests and scores

Who may not be able to join:

  • You have a history of an irregular heart rhythm called atrial fibrillation or atrial flutter
  • You were born with a heart defect (congenital heart disease)
  • You had a heart procedure to open a blocked artery (coronary stent or balloon procedure) within the last 3 months due to an emergency
  • You have an overactive thyroid that is not currently under control
  • You have very advanced kidney disease (end-stage kidney failure)
  • Your heart or circulation is currently unstable
  • You have another serious illness or condition where life expectancy is expected to be less than one year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 886-2-28727794

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tze-Fan Chao
Registry
ClinicalTrials.gov
Start date
17 March 2025
Est. completion
31 December 2031

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

the detection of AF either by 12-lead ECG or any episodes of AF lasting ≥ 30 seconds by the single-lead ECG or 7-day continuous recording.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov